Scientists at the Miami VA Healthcare System have invented a novel treatment for pulmonary fibrosis and cancer that involves administration of growth hormone-releasing hormone (GHRH) peptides.

From enhancing wound healing to combating neurodegeneration and cancer, growth hormone-releasing hormone and its analogs reveal groundbreaking roles that could redefine future therapies.

These tumors either produce growth hormone themselves or make another substance, known as growth-hormone-releasing hormone, which, in turn, prompts the pituitary gland to make more growth hormone.

As we all age, the amount of growth hormone produced by the body decreases. This results in a reduction in lean muscle mass, slower metabolism, and can have negative effects on energy and sleep.

CJC-1295 is a modified form of growth hormone-releasing hormone (GHRH) with a longer half-life than other growth hormone stimulants, such as Sermorelin. Research into CJC-1295 suggests that its ...

Additionally, research on Growth Hormone-Releasing Hormone (GHRH) and its antagonists has revealed their potential in mitigating endothelial inflammation. GHRH antagonists have been shown to ...

Mod GRF, also referred to as Modified Growth Hormone Releasing Factor, is a synthetic analog of growth hormone-releasing hormone (GHRH). It is designed to mimic the sequence of endogenous GHRH while ...